Calmare Therapeutics Incorporated has been awarded a preliminary three-month extension of its General Services Administration military contract (V797P-4300B). First awarded in 2010, the company's contract extension is designed to continue the streamlined procurement process for U.S. military personnel and their families and institutional customers across the globe who acquire Calmare Pain Therapy Devices and its consumables.
Calmare Therapeutics Incorporated
Equities
CTTC
US13126R1023
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |